Literature DB >> 20051019

Dual pathology in Rasmussen's encephalitis: a study of seven cases and review of the literature.

Hidehiro Takei1, Angus Wilfong, Amy Malphrus, Daniel Yoshor, Jill V Hunter, Dawna L Armstrong, Meenakshi B Bhattacharjee.   

Abstract

Dual pathology has previously been reported in less than 10% of cases of Rasmussen's encephalitis (RE). Given the rarity of RE, it appears unlikely that dual pathology in RE is merely a coincidence. We therefore reviewed all cases of RE experienced in our institution to assess for an additional/associated pathology. A total of seven patients with RE were identified in our archives. Seven children (4 boys and 3 girls, age range: 3-16 years, mean: 9.5 years) with medically refractory epilepsy underwent surgical resection for intractable seizures. The surgical specimens were examined with routine neurohistological techniques, and immunohistochemistry was performed with an extensive panel of antibodies for viruses, lymphocytes, microglia/macrophages, human leukocyte antigen (HLA)-DR, astrocytes, and neurons. Relevant literature was reviewed. Microscopically, all seven cases demonstrated the inflammatory pathology of RE in the cortex and white matter with leptomeningeal and perivascular lymphocytic infiltration, microglial nodules with/without neuronophagia, neuronal loss and gliosis. The HLA-DR antibody was extremely helpful in highlighting the extent of microglial cell proliferation/activation that was not appreciable with standard histology. An unexpected finding in all seven cases was the presence of cortical dysplasia. In our series of seven cases, there was co-occurrence of the inflammatory/destructive pathology of RE with malformative/dysplastic features in cortical architecture in 100% of cases, raising questions about the possible relationships between the two entities. Awareness of the possibility of dual pathology in RE is important for clinical and pathological diagnosis, and may affect the management and outcome of these patients. Immunohistochemistry is very helpful to make a definitive diagnosis of both pathologies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20051019     DOI: 10.1111/j.1440-1789.2009.01079.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  15 in total

1.  Humanized mouse model of Rasmussen's encephalitis supports the immune-mediated hypothesis.

Authors:  Hania Kebir; Lionel Carmant; François Fontaine; Kathie Béland; Ciprian M Bosoi; Nathalie T Sanon; Jorge I Alvarez; Sébastien Desgent; Camille L Pittet; David Hébert; Marie-Josée Langlois; Rose-Marie Rébillard; Dang K Nguyen; Cécile Cieuta-Walti; Gregory L Holmes; Howard P Goodkin; John R Mytinger; Mary B Connolly; Alexandre Prat; Elie Haddad
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

Review 2.  Rasmussen encephalitis with dual pathology in a patient without seizures: case report and literature review.

Authors:  Vijay M Ravindra; Marcus D Mazur; Carrie A Mohila; Matthew T Sweney; Aimee Hersh; Robert J Bollo
Journal:  Childs Nerv Syst       Date:  2015-06-02       Impact factor: 1.475

Review 3.  Mechanisms of epileptogenesis in pediatric epileptic syndromes: Rasmussen encephalitis, infantile spasms, and febrile infection-related epilepsy syndrome (FIRES).

Authors:  Carlos A Pardo; Rima Nabbout; Aristea S Galanopoulou
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 4.  Rasmussen's encephalitis: clinical features, pathobiology, and treatment advances.

Authors:  Sophia Varadkar; Christian G Bien; Carol A Kruse; Frances E Jensen; Jan Bauer; Carlos A Pardo; Angela Vincent; Gary W Mathern; J Helen Cross
Journal:  Lancet Neurol       Date:  2014-02       Impact factor: 44.182

5.  "Mirror EPC": epilepsia partialis continua shifting sides after rolandic resection in dysplasia.

Authors:  Marta Hemb; Eliseu Paglioli; François Dubeau; Frederick Andermann; André Olivier; Jaderson C da Costa; William A Martins; Magda L Nunes; André Palmini
Journal:  Neurology       Date:  2014-09-12       Impact factor: 9.910

6.  Encephalomalacic dysplastic mass lesion associated with vascular abnormalities in an elderly man. Is this "acquired" focal cortical dysplasia?

Authors:  Hidehiro Takei; Meenakshi B Bhattacharjee
Journal:  Int J Clin Exp Pathol       Date:  2013-09-15

7.  Dual Pathology in Rasmussen's Encephalitis: A Report of Coexistent Focal Cortical Dysplasia and Review of the Literature.

Authors:  Richard A Prayson
Journal:  Case Rep Pathol       Date:  2012-09-29

8.  Evidence for the involvement of gamma delta T cells in the immune response in Rasmussen encephalitis.

Authors:  Geoffrey C Owens; Kate L Erickson; Colin C Malone; Calvin Pan; My N Huynh; Julia W Chang; Thabiso Chirwa; Harry V Vinters; Gary W Mathern; Carol A Kruse
Journal:  J Neuroinflammation       Date:  2015-07-19       Impact factor: 8.322

9.  Upregulation of adenosine kinase in Rasmussen encephalitis.

Authors:  Guoming Luan; Qing Gao; Yuguang Guan; Feng Zhai; Jian Zhou; Changqing Liu; Yin Chen; Kun Yao; Xueling Qi; Tianfu Li
Journal:  J Neuropathol Exp Neurol       Date:  2013-11       Impact factor: 3.685

10.  Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies.

Authors:  Joan Liu; Cheryl Reeves; Zuzanna Michalak; Antonietta Coppola; Beate Diehl; Sanjay M Sisodiya; Maria Thom
Journal:  Acta Neuropathol Commun       Date:  2014-07-08       Impact factor: 7.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.